Not applicableStudy completedNCT03824561What this trial is testingSpecial Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]Who this might be right forUlcerative Colitis Takeda 1,110
Large-scale testing (Phase 3)Study completedNCT02039505What this trial is testingPhase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisWho this might be right forUlcerative Colitis Takeda 292
Large-scale testing (Phase 3)UnknownNCT05771155What this trial is testingEfficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®Who this might be right forUlcerative Colitis Polpharma Biologics S.A. 750
Testing effectiveness (Phase 2)Study completedNCT03558152What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Genentech, Inc. 195
Large-scale testing (Phase 3)Study completedNCT00783718What this trial is testingStudy of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Millennium Pharmaceuticals, Inc. 895
Not applicableStudy completedNCT04002180What this trial is testingSpecified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]Who this might be right forCrohn's Disease Takeda 335
Not applicableLooking for participantsNCT07198113What this trial is testingCOMPARE - Pediatric Inflammatory Bowel Disease (PIBD)Who this might be right forUlcerative Colitis, PediatricInflammatory Bowel DiseasesCrohn Disease University of North Carolina, Chapel Hill 1,100
Not applicableUnknownNCT03375424What this trial is testingVedolizumab Study With Inflammatory Bowel Disease Patients in GermanyWho this might be right forInflammatory Bowel DiseasesTreatment Ced Service GmbH 2,500
Large-scale testing (Phase 3)Study completedNCT03234907What this trial is testingVedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.Who this might be right forCrohn's Disease Takeda 215
Post-approval studies (Phase 4)Looking for participantsNCT06095128What this trial is testingVedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Takeda 60
Testing effectiveness (Phase 2)Looking for participantsNCT06815003What this trial is testingVedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more City of Hope Medical Center 35
Not applicableStudy completedNCT05504915What this trial is testingReal World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center OsijekWho this might be right forInflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative Osijek University Hospital 31
Post-approval studies (Phase 4)Study completedNCT04804540What this trial is testingVedolizumab in People With Ulcerative Colitis and Crohn's DiseaseWho this might be right forUlcerative ColitisCrohn Disease Takeda 150
Not applicableStudy completedNCT04959851What this trial is testingA Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)Who this might be right forInflammatory Bowel DiseasesColitis, UlcerativeCrohns Disease Takeda 185
Not applicableLooking for participantsNCT05186623What this trial is testingPrediction Model for Response to Biologics and Small Molecular Agent for UCWho this might be right forUlcerative Colitis Asan Medical Center 300
Not applicableStudy completedNCT03056924What this trial is testingImmunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With VedolizumabWho this might be right forInflammatory Bowel Diseases Boston Medical Center 173
Not applicableStudy completedNCT05596422What this trial is testingVedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)Who this might be right forInflammatory Bowel Disease (IBD)Ulcerative ColitisCrohn's Disease Takeda 423
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247What this trial is testingInfliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or MelanomaWho this might be right forColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more M.D. Anderson Cancer Center 47
Large-scale testing (Phase 3)Active Not RecruitingNCT03221036What this trial is testingEfficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative ColitisWho this might be right forModerately to Severely Active Ulcerative Colitis Takeda 392
Post-approval studies (Phase 4)Looking for participantsNCT06045754What this trial is testingVedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 50